191 related articles for article (PubMed ID: 21574948)
1. Modeling of HIV-1 TAR RNA-ligand complexes.
Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
[TBL] [Abstract][Full Text] [Related]
2. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
Filikov AV; Mohan V; Vickers TA; Griffey RH; Cook PD; Abagyan RA; James TL
J Comput Aided Mol Des; 2000 Aug; 14(6):593-610. PubMed ID: 10921774
[TBL] [Abstract][Full Text] [Related]
3. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
[TBL] [Abstract][Full Text] [Related]
4. Tertiary Element Interaction in HIV-1 TAR.
Krawczyk K; Sim AY; Knapp B; Deane CM; Minary P
J Chem Inf Model; 2016 Sep; 56(9):1746-54. PubMed ID: 27500460
[TBL] [Abstract][Full Text] [Related]
5. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
[TBL] [Abstract][Full Text] [Related]
6. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
Du Z; Lind KE; James TL
Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
[TBL] [Abstract][Full Text] [Related]
7. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
Shortridge MD; Wille PT; Jones AN; Davidson A; Bogdanovic J; Arts E; Karn J; Robinson JA; Varani G
Nucleic Acids Res; 2019 Feb; 47(3):1523-1531. PubMed ID: 30481318
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
Zhao H; Li J; Jiang L
Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707
[TBL] [Abstract][Full Text] [Related]
10. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
11. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
[TBL] [Abstract][Full Text] [Related]
12. Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.
Morgner N; Barth HD; Brutschy B; Scheffer U; Breitung S; Göbel M
J Am Soc Mass Spectrom; 2008 Nov; 19(11):1600-11. PubMed ID: 18693035
[TBL] [Abstract][Full Text] [Related]
13. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
Lu J; Nguyen L; Zhao L; Xia T; Qi X
Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
[TBL] [Abstract][Full Text] [Related]
14. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
Xie B; Calabro V; Wainberg MA; Frankel AD
J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
[TBL] [Abstract][Full Text] [Related]
15. Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.
Zeiger M; Stark S; Kalden E; Ackermann B; Ferner J; Scheffer U; Shoja-Bazargani F; Erdel V; Schwalbe H; Göbel MW
Bioorg Med Chem Lett; 2014 Dec; 24(24):5576-5580. PubMed ID: 25466178
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
[TBL] [Abstract][Full Text] [Related]
17. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
[TBL] [Abstract][Full Text] [Related]
18. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
Aboul-ela F; Karn J; Varani G
J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
[TBL] [Abstract][Full Text] [Related]
20. Probing interaction of a fluorescent ligand with HIV TAR RNA.
Qi L; Zhang J; He T; Huo Y; Zhang ZQ
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
